Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1967 1
1969 6
1970 4
1971 2
1972 2
1973 4
1974 5
1975 4
1976 5
1978 1
1979 4
1980 8
1981 8
1982 8
1983 8
1984 8
1985 10
1986 7
1987 16
1988 6
1989 19
1990 17
1991 20
1992 16
1993 31
1994 18
1995 14
1996 25
1997 29
1998 27
1999 28
2000 36
2001 40
2002 49
2003 45
2004 49
2005 56
2006 44
2007 49
2008 45
2009 49
2010 35
2011 40
2012 54
2013 49
2014 58
2015 53
2016 44
2017 43
2018 53
2019 49
2020 42
2021 50
2022 61
2023 57
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,429 results

Results by year

Filters applied: . Clear all
Page 1
HELLP Syndrome: Pathophysiology and Current Therapies.
Wallace K, Harris S, Addison A, Bean C. Wallace K, et al. Curr Pharm Biotechnol. 2018;19(10):816-826. doi: 10.2174/1389201019666180712115215. Curr Pharm Biotechnol. 2018. PMID: 29998801 Review.
HELLP syndrome is a disorder associated with serious maternal morbidity and mortality. ...Differential diagnoses include acute fatty liver of pregnancy, thrombotic thrombocytopenic purpura, antiphospholipid syndrome, and hemolytic uremic synd
HELLP syndrome is a disorder associated with serious maternal morbidity and mortality. ...Differential diagnoses include acute fatty …
Renal Thrombotic Microangiopathy: A Review.
Genest DS, Patriquin CJ, Licht C, John R, Reich HN. Genest DS, et al. Am J Kidney Dis. 2023 May;81(5):591-605. doi: 10.1053/j.ajkd.2022.10.014. Epub 2022 Dec 10. Am J Kidney Dis. 2023. PMID: 36509342 Review.
Thrombotic microangiopathy (TMA), a pathological lesion observed in a wide spectrum of diseases, is triggered by endothelial injury and/or dysfunction. ...Major advances have been made with respect to the pathophysiology of primary TMA entities, with the subsequent develop
Thrombotic microangiopathy (TMA), a pathological lesion observed in a wide spectrum of diseases, is triggered by endothelial injury a
Thrombotic thrombocytopenic purpura.
Kremer Hovinga JA, Coppo P, Lämmle B, Moake JL, Miyata T, Vanhoorelbeke K. Kremer Hovinga JA, et al. Nat Rev Dis Primers. 2017 Apr 6;3:17020. doi: 10.1038/nrdp.2017.20. Nat Rev Dis Primers. 2017. PMID: 28382967 Review.
Thrombotic thrombocytopenic purpura (TTP; also known as Moschcowitz disease) is characterized by the concomitant occurrence of often severe thrombocytopenia, microangiopathic haemolytic anaemia and a variable degree of ischaemic organ damage, particularly aff
Thrombotic thrombocytopenic purpura (TTP; also known as Moschcowitz disease) is characterized by the concomitant occurr
Syndromes of thrombotic microangiopathy.
George JN, Nester CM. George JN, et al. N Engl J Med. 2014 Aug 14;371(7):654-66. doi: 10.1056/NEJMra1312353. N Engl J Med. 2014. PMID: 25119611 Free article. Review.
Haemolytic uremic syndrome: diagnosis and management.
Sheerin NS, Glover E. Sheerin NS, et al. F1000Res. 2019 Sep 25;8:F1000 Faculty Rev-1690. doi: 10.12688/f1000research.19957.1. eCollection 2019. F1000Res. 2019. PMID: 31598213 Free PMC article. Review.
The thrombotic microangiopathies (TMAs) are a group of diseases characterised by microangiopathic haemolysis, thrombocytopenia, and thrombus formation leading to tissue injury. Traditionally, TMAs have been classified as either thrombotic thrombocytopenic
The thrombotic microangiopathies (TMAs) are a group of diseases characterised by microangiopathic haemolysis, thrombocytopenia, and t …
Advances in the management of TTP.
Subhan M, Scully M. Subhan M, et al. Blood Rev. 2022 Sep;55:100945. doi: 10.1016/j.blre.2022.100945. Epub 2022 Feb 17. Blood Rev. 2022. PMID: 35216839 Review.
Thrombotic thrombocytopenic purpura is an acute life-threatening disorder, associated with a mortality of 90% if unrecognised and untreated. ...
Thrombotic thrombocytopenic purpura is an acute life-threatening disorder, associated with a mortality of 90% if unreco
An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura.
Joly BS, Coppo P, Veyradier A. Joly BS, et al. Expert Rev Hematol. 2019 Jun;12(6):383-395. doi: 10.1080/17474086.2019.1611423. Epub 2019 May 20. Expert Rev Hematol. 2019. PMID: 31107120 Review.
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, consumption thrombocytopenia, and organ injury. ...
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopath …
Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
Hanna RM, Henriksen K, Kalantar-Zadeh K, Ferrey A, Burwick R, Jhaveri KD. Hanna RM, et al. Adv Chronic Kidney Dis. 2022 Mar;29(2):149-160.e1. doi: 10.1053/j.ackd.2021.11.006. Adv Chronic Kidney Dis. 2022. PMID: 35817522 Review.
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolytic anemia with end-organ dysfunction. Thrombotic thrombocytopenic purpura results from von Willebrand factor multimerization, Shiga toxin-mediated hemoly
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolytic anemia with end-organ dysfuncti
[Thrombotic thrombocytopenic purpura].
Hansen DL, Nilsson AC, Frederiksen H. Hansen DL, et al. Ugeskr Laeger. 2021 Oct 18;183(42):V03210230. Ugeskr Laeger. 2021. PMID: 34709162 Free article. Review. Danish.
Distinguishing thrombotic thrombocytopenic purpura (TTP) from other thrombotic microangiopathies requires measurement of ADAMTS13 enzyme activity, but treatment must often be commenced before results from the ADAMTS13 analysis is available. ...
Distinguishing thrombotic thrombocytopenic purpura (TTP) from other thrombotic microangiopathies requires measur …
Clinical and laboratory diagnosis of TTP: an integrated approach.
Chiasakul T, Cuker A. Chiasakul T, et al. Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):530-538. doi: 10.1182/asheducation-2018.1.530. Hematology Am Soc Hematol Educ Program. 2018. PMID: 30504354 Free PMC article. Review.
Thrombotic thrombocytopenia purpura (TTP) is a rare, life-threatening disease with an incidence of approximately 2 persons per million per year. ...Diagnosis of TTP is challenging because of its diverse clinical manifestations, overlap in clinical presentation with
Thrombotic thrombocytopenia purpura (TTP) is a rare, life-threatening disease with an incidence of approximately 2 persons per
1,429 results